Afghanistan - Incidence of tuberculosis (per 100,000 people)

Incidence of tuberculosis (per 100,000 people) in Afghanistan was reported at 189 in 2015, according to the World Bank collection of development indicators, compiled from officially recognized sources.



afghanistan incidence of tuberculosis per 100 000 people wb data
Please Paste this Code in your Website
width
height
 Preview




We will not not share your email with third parties and you can unsubscribe at any time.
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

Learn More Register Login
The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Learn More Interested? Click here to contact us




Incidence of tuberculosis is the estimated number of new pulmonary, smear positive, and extra-pulmonary tuberculosis cases.


Afghanistan | Health

Women who believe a husband is justified in beating his wife (any of five reasons)
90.2 %
Total alcohol consumption per capita (liters of pure alcohol, projected estimates, 15+ years of age)
1
Prevalence of anemia among women of reproductive age (% of women ages 15-49)
33 %
Prevalence of anemia among children (% of children under 5)
44.2 %
Prevalence of anemia among non-pregnant women (% of women ages 15-49)
31.4 %
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions (% of total)
39.4 %
Number of infant deaths
67399
Cause of death, by injury (% of total)
18.1 %
Number of under-five deaths
94261
Cause of death, by non-communicable diseases (% of total)
42.3 %
Number of neonatal deaths
36242
Adults (ages 15+) living with HIV
6700 Persons
AIDS estimated deaths (UNAIDS estimates)
500
Female adults with HIV (% of population ages 15+ with HIV)
28.58 %
Prevalence of HIV, total (% of population ages 15-49)
0.1 %
Mortality rate, under-5 (per 1,000)
91.1
Mortality rate, under-5, female (per 1,000 live births)
87.4
Mortality rate, under-5, male (per 1,000 live births)
94.6
Under-5 mortality rate (per 1,000 live births): Q1 (lowest)
104
Under-5 mortality rate (per 1,000 live births): Q2
94
Under-5 mortality rate (per 1,000 live births): Q3
112
Under-5 mortality rate (per 1,000 live births): Q4
113
Under-5 mortality rate (per 1,000 live births): Q5 (highest)
84
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70
31 %
Mortality rate; neonatal (per 1;000 live births)
35.5
Demand for family planning satisfied by modern methods (% of married women with demand for family planning)
42.2 %
Children (0-14) living with HIV
500 Persons
Prevalence of HIV, female (% ages 15-24)
0.1 %
Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)
1.8
Prevalence of HIV, male (% ages 15-24)
0.1 %
Antiretroviral therapy coverage (% of people with advanced HIV infection)
5 %
Adults (ages 15+) newly infected with HIV
1000
Children (ages 0-14) newly infected with HIV
100
Adults (ages 15+) and children (ages 0-14) newly infected with HIV
1000
Incidence of HIV (% of uninfected population ages 15-49)
0.01 %
% of females ages 15-49 having comprehensive correct knowledge about HIV (2 prevent ways and reject 3 misconceptions)
1.5 %
Children orphaned by HIV/AIDS
4000
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
4 %
Adults (ages 15+) and children (0-14 years) living with HIV
6900 Persons
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q1 (lowest)
23.1 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q2
30 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q3
28.2 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q4
32.7 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q5 (highest)
37.3 %
Immunization, Hib3 (% of children ages 12-23 months)
78 %
Immunization, BCG (% of one-year-old children)
86 %
Vaccinations (BCG) (% of children ages 12-23 months): Q1 (lowest)
54.4 %
Vaccinations (BCG) (% of children ages 12-23 months): Q2
63 %
Vaccinations (BCG) (% of children ages 12-23 months): Q3
59.8 %
Vaccinations (BCG) (% of children ages 12-23 months): Q4
66.8 %
Vaccinations (BCG) (% of children ages 12-23 months): Q5 (highest)
79.3 %
Immunization, DPT (% of children ages 12-23 months)
78 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q1 (lowest)
28.9 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q2
40.1 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q3
36.4 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q4
43.5 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q5 (highest)
54.4 %
Immunization, measles (% of children ages 12-23 months)
68 %
Vaccinations (Measles) (% of children ages 12-23 months): Q1 (lowest)
43.7 %
Vaccinations (Measles) (% of children ages 12-23 months): Q2
55.6 %
Vaccinations (Measles) (% of children ages 12-23 months): Q3
52.2 %
Vaccinations (Measles) (% of children ages 12-23 months): Q4
59.7 %
Vaccinations (Measles) (% of children ages 12-23 months): Q5 (highest)
68.1 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q1 (lowest)
27.6 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q2
24.3 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q3
28.1 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q4
25.8 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q5 (highest)
13 %
Immunization, Pol3 (% of one-year-old children)
77 %
Hospital beds
0.5
Nurses and midwives
0.073
Physicians
0.266
Specialist surgical workforce (per 100,000 population)
0.03
Notified cases of malaria (per 100;000 people)
2428
Incidence of malaria (per 1,000 population at risk)
23.6
Use of insecticide-treated bed nets (% of under-5 population)
4.6 %
Children with fever receiving antimalarial drugs (% of children under age 5 with fever)
11.8 %
Number of maternal mortality deaths
4300
Lifetime risk of maternal death (1 in: rate varies by country)
52
Lifetime risk of maternal death
1.93 %
Prevalence of anemia among pregnant women
44.4 %
Smoking prevalence, females (% of adults)
17 %
Smoking prevalence, males (% of adults)
82 %
Risk of catastrophic expenditure for surgical care (% of people at risk)
92.8 %
Risk of impoverishing expenditure for surgical care (% of people at risk)
83.1 %
Improved sanitation facilities (% of population with access)
31.9 %
Improved sanitation facilities, urban (% of urban population with access)
45.1 %
Pregnant women receiving prenatal care of at least four visits (% of pregnant women)
17.8 %
Antenatal care (any skilled personnel) (% of women with a birth): Q1 (lowest)
25.8 %
Antenatal care (any skilled personnel) (% of women with a birth): Q2
37.7 %
Antenatal care (any skilled personnel) (% of women with a birth): Q3
42.3 %
Antenatal care (any skilled personnel) (% of women with a birth): Q4
56.2 %
Antenatal care (any skilled personnel) (% of women with a birth): Q5 (highest)
78.1 %
Pregnant women receiving prenatal care
58.6 %
Antenatal care (doctor) (% of women with a birth): Q1 (lowest)
16.7 %
Antenatal care (doctor) (% of women with a birth): Q2
18.1 %
Antenatal care (doctor) (% of women with a birth): Q3
22.4 %
Antenatal care (doctor) (% of women with a birth): Q4
31.6 %
Antenatal care (doctor) (% of women with a birth): Q5 (highest)
55.9 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q1 (lowest)
46.4 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q2
59.7 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q3
65.6 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q4
63.5 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q5 (highest)
65.7 %
ARI treatment (% of children under 5 taken to a health provider)
61.5 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q1 (lowest)
15.7 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q2
18.7 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q3
20.7 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q4
18.6 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q5 (highest)
19.3 %
Exclusive breastfeeding (% of children under 6 months)
83 %
Assistance during delivery (any skilled personnel) (% of births): Q1 (lowest)
15.6 %
Assistance during delivery (any skilled personnel) (% of births): Q2
24.9 %
Assistance during delivery (any skilled personnel) (% of births): Q3
31 %
Assistance during delivery (any skilled personnel) (% of births): Q4
46.6 %
Assistance during delivery (any skilled personnel) (% of births): Q5 (highest)
76.3 %
Births attended by skilled health staff (% of total)
38.6 %
Place of delivery (births at health facility) (% of births): Q1 (lowest)
12.5 %
Place of delivery (births at health facility) (% of births): Q2
20.6 %
Place of delivery (births at health facility) (% of births): Q3
26.8 %
Place of delivery (births at health facility) (% of births): Q4
38.3 %
Place of delivery (births at health facility) (% of births): Q5 (highest)
67.4 %
Assistance during delivery (doctor) (% of births): Q1 (lowest)
8.4 %
Assistance during delivery (doctor) (% of births): Q2
7.9 %
Assistance during delivery (doctor) (% of births): Q3
14.8 %
Assistance during delivery (doctor) (% of births): Q4
20.9 %
Assistance during delivery (doctor) (% of births): Q5 (highest)
50.1 %
Low-birthweight babies (% of births)
20 %
Diabetes prevalence (% of population ages 20 to 79)
8.8 %
Prevalence of diarrhea (% of children under 5): Q1 (lowest)
22 %
Prevalence of diarrhea (% of children under 5): Q2
22.2 %
Prevalence of diarrhea (% of children under 5): Q3
25.1 %
Prevalence of diarrhea (% of children under 5): Q4
25 %
Prevalence of diarrhea (% of children under 5): Q5 (highest)
19.8 %
Infant and young child feeding practices, all 3 IYCF (% children ages 6-23 months)
15.5 %
Prevalence of underweight, weight for age, female (% of children under 5)
33 %
Prevalence of underweight, weight for age, male (% of children under 5)
32.7 %
Malnutrition prevalence, weight for age (% of children under 5)
32.9 %
Malaria cases reported
86895
Maternal mortality ratio (modeled estimate, per 100,000 live births)
396
Maternal mortality ratio (national estimate; per 100;000 live births)
1291
People practicing open defecation, rural (% of rural population)
17.4 %
People practicing open defecation, urban (% of urban population)
0 %
People practicing open defecation (% of population)
12.7 %
Diarrhea treatment (% of children under 5 receiving oral rehydration and continued feeding)
40.7 %
Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q1 (lowest)
75 %
Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q2
68.8 %
Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q3
66.7 %
Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q4
72.9 %
Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q5 (highest)
66.4 %
Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q1 (lowest)
68.7 %
Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q2
63.4 %
Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q3
61.8 %
Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q4
63.4 %
Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q5 (highest)
59 %
Diarrhea treatment (% of children under 5 who received ORS packet)
46.2 %
Prevalence of overweight, female (% of female adults)
20.2 %
Prevalence of overweight, male (% of male adults)
13.2 %
Prevalence of overweight, weight for height, female (% of children under 5)
2.6 %
Prevalence of overweight, weight for height, male (% of children under 5)
6.3 %
Prevalence of overweight (% of children under 5)
4.6 %
Postnatal care coverage (% mothers)
39.9 %
Prevalence of stunting, height for age, female (% of children under 5)
58.5 %
Prevalence of stunting, height for age, male (% of children under 5)
60 %
Malnutrition prevalence, height for age (% of children under 5)
59.3 %
Suicide mortality rate (per 100,000 population)
5.5
Mortality caused by road traffic injury (per 100,000 people)
15.2
Prevalence of wasting, weight for height, female (% of children under 5)
9.3 %
Prevalence of wasting, weight for height, male (% of children under 5)
7.9 %
Prevalence of wasting (% of children under 5)
8.6 %
Prevalence of severe wasting, weight for height, female (% of children under 5)
4.3 %
Prevalence of severe wasting, weight for height, male (% of children under 5)
2.9 %
Prevalence of severe wasting, weight for height (% of children under 5)
3.5 %
Tuberculosis treatment success rate (% of registered cases)
87 %
Tuberculosis case detection rate (all forms)
58 %
Incidence of tuberculosis (per 100,000 people)
189
Tuberculosis death rate (per 100,000 people)
37
Tetanus toxoid vaccination (% of live births): Q1 (lowest)
24.6 %
Tetanus toxoid vaccination (% of live births): Q2
28.7 %
Tetanus toxoid vaccination (% of live births): Q3
30.4 %
Tetanus toxoid vaccination (% of live births): Q4
34.5 %
Tetanus toxoid vaccination (% of live births): Q5 (highest)
35.2 %
Newborns protected against tetanus
70 %
External resources for health (% of total expenditure on health)
23 %
Out-of-pocket health expenditure (% of total expenditure on health)
63.88 %
Out-of-pocket health expenditure (% of private expenditure on health)
99.56 %
Health expenditure per capita
56.57 USD
Health expenditure per capita, PPP (constant 2005 international $)
167
Health expenditure, private (% of GDP)
5.25 %
Health expenditure, public (% of total health expenditure)
35.84 %
Health expenditure, public (% of government expenditure)
12 %
Health expenditure, public (% of GDP)
2.93 %
Health expenditure, total (% of GDP)
8.18 %
Refugee population by country or territory of asylum
257554
Refugee population by country or territory of origin
2666254
Number of people who are undernourished
8600000
Prevalence of undernourishment (% of population)
26.8 %
Depth of the food deficit (kilocalories per person per day)
173
Consumption of iodized salt (% of households)
20.45 %
Vitamin A supplements for children (% of children ages 6-59 months): Q1 (lowest)
43.9 %
Vitamin A supplements for children (% of children ages 6-59 months): Q2
48.3 %
Vitamin A supplements for children (% of children ages 6-59 months): Q3
49.5 %
Vitamin A supplements for children (% of children ages 6-59 months): Q4
51.5 %
Vitamin A supplements for children (% of children ages 6-59 months): Q5 (highest)
62.4 %
Vitamin A supplementation coverage rate (% of children ages 6-59 months)
95 %
Adolescent fertility rate (births per 1,000 women ages 15-19)
71.2
Mortality rate, adult, female (per 1,000 female adults)
234
Mortality rate, adult, male (per 1,000 male adults)
277
Birth rate, crude
33.31
Death rate, crude
8.03
Current use of contraception (modern method) (% of married women): Q1 (lowest)
14.2 %
Current use of contraception (modern method) (% of married women): Q2
12.4 %
Current use of contraception (modern method) (% of married women): Q3
17.5 %
Current use of contraception (modern method) (% of married women): Q4
21 %
Current use of contraception (modern method) (% of married women): Q5 (highest)
33.3 %
Contraceptive prevalence, modern methods (% of women ages 15-49)
19.8 %
Current use of contraception (any method) (% of married women): Q1 (lowest)
15.2 %
Current use of contraception (any method) (% of married women): Q2
13.6 %
Current use of contraception (any method) (% of married women): Q3
18.6 %
Current use of contraception (any method) (% of married women): Q4
22.6 %
Current use of contraception (any method) (% of married women): Q5 (highest)
37.2 %
Contraceptive prevalence (% of women ages 15-49)
22.5 %
Mortality rate, infant, female (per 1,000 live births)
62.1
Mortality rate, infant (per 1,000 live births)
66.3
Mortality rate, infant, male (per 1,000 live births)
70.3
Infant mortality rate (per 1,000 live births): Q1 (lowest)
75
Infant mortality rate (per 1,000 live births): Q2
68
Infant mortality rate (per 1,000 live births): Q3
80
Infant mortality rate (per 1,000 live births): Q4
80
Infant mortality rate (per 1,000 live births): Q5 (highest)
62
Life expectancy at birth, female (years)
61.97 years
Life expectancy at birth, total (years)
60.72 years
Life expectancy at birth, male (years)
59.52 years
Fertility rate, total (births per woman)
4.65
Survival to age 65, female (% of cohort)
61.61 %
Survival to age 65, male (% of cohort)
55.73 %
Wanted fertility rate (births per woman)
4.4
Women who were first married by age 18 (% of women ages 20-24)
32.8 %
Teenage mothers (% of women ages 15-19 who have had children or are currently pregnant)
12.1 %
Female population 00-04
2396000 Persons
Population ages 0-4, female (% of female population)
15.31 %
Male population 00-04
2529000 Persons
Population ages 0-4, male (% of male population)
15.13 %
Female population 05-09
2416000 Persons
Population ages 5-9, female (% of female population)
15.19 %
Male population 05-09
2534000 Persons
Population ages 5-9, male (% of male population)
14.96 %
Female population 10-14
2226000 Persons
Population ages 10-14, female (% of female population)
13.8 %
Male population 10-14
2353000 Persons
Population ages 10-14, male (% of male population)
13.7 %
Female population 15-19
1926000 Persons
Population ages 15-19, female (% of female population)
11.81 %
Male population 15-19
2041000 Persons
Population ages 15-19, male (% of male population)
11.76 %
Female population 20-24
1536000 Persons
Population ages 20-24, female (% of female population)
9.3 %
Male population 20-24
1654000 Persons
Population ages 20-24, male (% of male population)
9.46 %
Female population 25-29
1214000 Persons
Population ages 25-29, female (% of female population)
7.41 %
Male population 25-29
1340000 Persons
Population ages 25-29, male (% of male population)
7.7 %
Female population 30-34
1018000 Persons
Population ages 30-34, female (% of female population)
6.25 %
Male population 30-34
1115000 Persons
Population ages 30-34, male (% of male population)
6.43 %
Female population 35-39
825000 Persons
Population ages 35-39, female (% of female population)
5.01 %
Male population 35-39
920000 Persons
Population ages 35-39, male (% of male population)
5.27 %
Female population 40-44
647000 Persons
Population ages 40-44, female (% of female population)
3.93 %
Male population 40-44
725000 Persons
Population ages 40-44, male (% of male population)
4.13 %
Female population 45-49
515000 Persons
Population ages 45-49, female (% of female population)
3.15 %
Male population 45-49
566000 Persons
Population ages 45-49, male (% of male population)
3.24 %
Female population 50-54
410000 Persons
Population ages 50-54, female (% of female population)
2.51 %
Male population 50-54
444000 Persons
Population ages 50-54, male (% of male population)
2.55 %
Female population 55-59
327000 Persons
Population ages 55-59, female (% of female population)
2.01 %
Male population 55-59
341000 Persons
Population ages 55-59, male (% of male population)
1.96 %
Female population 60-64
254000 Persons
Population ages 50-64, female (% of female population)
1.58 %
Male population 60-64
256000 Persons
Population ages 50-64, male (% of male population)
1.48 %
Female population 65-69
206000 Persons
Population ages 65-69, female (% of female population)
1.28 %
Male population 65-69
181000 Persons
Population ages 65-69, male (% of male population)
1.04 %
Population ages 65 and above (% of total)
2.47 %
Female population 70-74
127000 Persons
Population ages 70-74, female (% of female population)
0.7502 %
Male population 70-74
113000 Persons
Population ages 70-74, male (% of male population)
0.642 %
Female population 75-79
70000 Persons
Population ages 75-79, female (% of female population)
0.4273 %
Male population 75-79
60000 Persons
Population ages 75-79, male (% of male population)
0.3387 %
Population ages 80 and above, female
47000 Persons
Population ages 80 and above, female (% of female population)
0.276 %
Male population 80+
36000 Persons
Population ages 80 and above, male (% of male population)
0.1983 %
Age population, age 06, female, interpolated
485070 Persons
Age population, age 06, male, interpolated
508109 Persons
Age population, age 07, female, interpolated
480247 Persons
Age population, age 07, male, interpolated
503483 Persons
Age population, age 08, female, interpolated
473815 Persons
Age population, age 08, male, interpolated
497391 Persons
Age population, age 09, female, interpolated
465947 Persons
Age population, age 09, male, interpolated
489942 Persons
Age population, age 10, female, interpolated
456660 Persons
Age population, age 10, male
481223 Persons
Age population, age 11, female, interpolated
445971 Persons
Age population, age 11, male
471320 Persons
Age population, age 12, female, interpolated
434835 Persons
Age population, age 12, male
460464 Persons
Age population, age 13, female, interpolated
423740 Persons
Age population, age 13, male
448810 Persons
Age population, age 14, female, interpolated
412387 Persons
Age population, age 14, male
436399 Persons
Age population, age 15, female, interpolated
400282 Persons
Age population, age 15, male, interpolated
423357 Persons
Age population, age 16, female, interpolated
387871 Persons
Age population, age 16, male, interpolated
409952 Persons
Age population, age 17, female, interpolated
373963 Persons
Age population, age 17, male, interpolated
395511 Persons
Age population, age 18, female, interpolated
358029 Persons
Age population, age 18, male, interpolated
379811 Persons
Age population, age 19, female, interpolated
340903 Persons
Age population, age 19, male, interpolated
363405 Persons
Age population, age 20, female, interpolated
323974 Persons
Age population, age 20, male, interpolated
347056 Persons
Age population, age 21, female, interpolated
306997 Persons
Age population, age 21, male, interpolated
330586 Persons
Age population, age 22, female, interpolated
291301 Persons
Age population, age 22, male, interpolated
315404 Persons
Age population, age 23, female, interpolated
277702 Persons
Age population, age 23, male, interpolated
302279 Persons
Age population, age 24, female, interpolated
265698 Persons
Age population, age 24, male, interpolated
290665 Persons
Age population, age 25, female, interpolated
253775 Persons
Age population, age 25, male, interpolated
279146 Persons
Age dependency ratio (% of working-age population)
86.95 %
Age dependency ratio, old (% of working-age population)
4.62 %
Age dependency ratio, young (% of working-age population)
82.34 %
Population, female (% of total)
48.43 %
Completeness of birth registration, rural
36 %
Completeness of birth registration, urban
63.5 %
Completeness of birth registration
42.3 %
Unmet need for contraception (% of married women ages 15-49)
24.5 %